Variant report
Variant | nsv437084 |
---|---|
Chromosome Location | chr9:10559329-10590179 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192941092 | chr9:10561479-10561480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544989098 | chr9:10561485-10561486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185587348 | chr9:10561502-10561503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575347374 | chr9:10561511-10561512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs537517434 | chr9:10561524-10561525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544652504 | chr9:10561559-10561560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561408843 | chr9:10561561-10561562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530114458 | chr9:10561575-10561576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547045084 | chr9:10561590-10561591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574352876 | chr9:10561609-10561610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190516561 | chr9:10561662-10561663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532807390 | chr9:10561686-10561687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552618765 | chr9:10561702-10561703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369521533 | chr9:10561755-10561756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569389697 | chr9:10561773-10561774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538068603 | chr9:10561809-10561810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2038592 | chr9:10561818-10561819 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs143874171 | chr9:10561845-10561846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535837279 | chr9:10561868-10561869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs180801518 | chr9:10561874-10561875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566349769 | chr9:10561881-10561882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2757874 | chr9:10561884-10561885 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs114054290 | chr9:10561890-10561891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575381175 | chr9:10561916-10561917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544446561 | chr9:10561929-10561930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147324467 | chr9:10561944-10561945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371274606 | chr9:10562013-10562014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148784004 | chr9:10562014-10562015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533602765 | chr9:10562042-10562043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540738636 | chr9:10562075-10562076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183471797 | chr9:10562079-10562080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141579626 | chr9:10562080-10562081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546440644 | chr9:10562098-10562099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79900907 | chr9:10562109-10562110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115686747 | chr9:10562126-10562127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548417359 | chr9:10562142-10562143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568328294 | chr9:10562208-10562209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540207922 | chr9:10562224-10562225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10959168 | chr9:10562241-10562242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529695925 | chr9:10562303-10562304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553733577 | chr9:10562325-10562326 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560387380 | chr9:10562329-10562330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199672347 | chr9:10562330-10562331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78071764 | chr9:10562343-10562344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79807520 | chr9:10562344-10562345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112768571 | chr9:10562345-10562346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7849535 | chr9:10562354-10562355 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs188199065 | chr9:10562395-10562396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs35995022 | chr9:10562413-10562414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371078566 | chr9:10562416-10562417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10561400-10564200 | Enhancers | NHEK | skin |
2 | chr9:10561600-10562200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr9:10562000-10562800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr9:10562200-10562600 | Enhancers | HMEC | breast |
5 | chr9:10562200-10563800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr9:10562600-10563000 | Weak transcription | HMEC | breast |
7 | chr9:10562800-10563200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr9:10563000-10564200 | Enhancers | HMEC | breast |
9 | chr9:10563200-10563600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr9:10563800-10564200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr9:10571800-10572000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr9:10571800-10572000 | Enhancers | Spleen | Spleen |
13 | chr9:10586200-10587200 | Enhancers | NHEK | skin |